Mirna Therapeutics Inc Stock Nasdaq
Equities
US60470J1034
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 263K | Sales 2025 * | 4.48M | Capitalization | 21.66M |
---|---|---|---|---|---|
Net income 2024 * | -24M | Net income 2025 * | -43M | EV / Sales 2024 * | -21.8 x |
Net cash position 2024 * | 27.4M | Net cash position 2025 * | 67.4M | EV / Sales 2025 * | -10.2 x |
P/E ratio 2024 * |
-0.74
x | P/E ratio 2025 * |
-0.48
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.33% |
Managers | Title | Age | Since |
---|---|---|---|
Antoine Awad
CEO | Chief Executive Officer | 44 | 18-09-30 |
Mary Dooley
DFI | Director of Finance/CFO | 43 | 18-05-31 |
Brendan St Amant
LAW | General Counsel | - | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Shea
BRD | Director/Board Member | 72 | 17-08-27 |
Peter Barrett
CHM | Chairman | 71 | 17-08-27 |
Director/Board Member | 64 | 12-09-30 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |